European Position Paper on Rhinosinusitis and Nasal Polyps 2020
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objecti...
Publications
Explore 163 academic publications
Showing 12 of
163 publications
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
Complex interventions are commonly used in the health and social care services, public health practice, and other areas of social and economic policy that have consequences for ...
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Endovascular thrombectomy for ischemic stroke 6 to 16 hours after a patient was last known to be well plus standard medical therapy resulted in better functional outcomes than s...
Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone ϕ, ψ and Side-Chain χ<sub>1</sub> and χ<sub>2</sub> Dihedral Angles
While the quality of the current CHARMM22/CMAP additive force field for proteins has been demonstrated in a large number of applications, limitations in the model with respect t...
MANAJEMEN SUMBER DAYA MANUSIA
Buku ini sangat membantu bagi para dosen, mahasiswa, pengelola perusahaan, dan praktisi untuk memahami secara mendalam tentang bidang manajemen sumber daya manusia (MSDM). Saat ...
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
This Viewpoint from physicians with the Italian National Institute of Health confirms a higher case-fatality rate from coronavirus disease 2019 (COVID-19) in Italy compared with...
METODOLOGI PENELITIAN
Ilmu merupakan pengetahuan yang mencoba menafsirkan alam semesta ini seperti adanya, oleh karena itu manusia dalam menggali ilmu tidak dapat terlepas dari gejala-gejala yang ber...
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...